Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

被引:65
作者
Balzarini, Jan
Van Herrewege, Yven
Vermeire, Kurt
Vanham, Guido
Schols, Dominique
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Inst Trop Med, B-2000 Antwerp, Belgium
关键词
D O I
10.1124/mol.106.030155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exposure of HIV-1 to dendritic cell-specific intercellular adhesion molecule-3 -grabbing nonintegrin (DC-SIGN) -expressing B-lymphoblast Raji cells (Raji/DC-SIGN) but not to wild-type Raji/0 cells results in the capture of HIV-1 particles to the cells as measured by the quantification of cell-associated p24 antigen. Cocultivation of HIV-1 -captured Raji/DC-SIGN cells with uninfected CD4(+) T lymphocyte C8166 cells results in abundant formation of syncytia within 36 h after cocultivation. Short pre-exposure of HIV-1 to carbohydrate-binding agents (CBA) dose dependently prevents the Raji/DC-SIGN cells from efficiently binding the virus particles, and no syncytia formation occurs upon subsequent cocultivation with C8166 cells. Thus, the mannose-specific [i. e., the plant lectins Hippeastrum hybrid agglutinin (HHA), Galanthus nivalis agglutinin (GNA), Narcissus pseudonarcissus agglutinin; and Cymbidium agglutinin (CA); the procaryotic cyanovirin-N (CV-N); and the monoclonal antibody 2G12) and N-acetylglucosamine-specific (i. e., the plant lectin Urtica dioica agglutinin) CBAs efficiently abrogate the DC-SIGN-directed HIV-1 capture and subsequent transmission to T lymphocytes. In this assay, the CD4-down-regulating cyclotriazodisulfonamide derivative, the CXCR4 and CCR5 coreceptor antagonists 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl) phenyl] methyl] -1,4,8,11-tetrazacyclotetradecane (AMD3100) and maraviroc, the gp41-binding enfuvirtide, and the polyanionic substances dextran sulfate (M-r 5000), sulfated polyvinyl alcohol, and the naphthalene sulfonate polymer PRO-2000 were markedly less efficient or even completely ineffective. Similar observations were made in primary monocyte-derived dendritic cell cultures that were infected with HIV-1 particles that had been shortly pre-exposed to the CBAs CV-N, CA, HHA, and GNA and the polyanions DS-5000 and PRO-2000. The potential of CBAs, but not polyanions and other structural/functional classes of entry inhibitors, to impair DC-SIGN-expressing cells in their capacity of transmitting HIV to T lymphocytes might be an important property to be taken into consideration in the eventual choice to move microbicide candidate drugs to the clinical setting.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 28 条
  • [1] BABA M, 1990, J ACQ IMMUN DEF SYND, V3, P493
  • [2] NOVEL SULFATED POLYMERS AS HIGHLY POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION AND GIANT-CELL FORMATION
    BABA, M
    SCHOLS, D
    DECLERCO, E
    PAUWELS, R
    NAGY, M
    GYORGYIEDELENYI, J
    LOW, M
    GOROG, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) : 134 - 138
  • [3] Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection
    Balzarini, J
    Hatse, S
    Vermeire, K
    Princen, K
    Aquaro, S
    Perno, CF
    De Clercq, E
    Egberink, H
    Vanden Mooter, G
    Peumans, W
    Van Damme, E
    Schols, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 3858 - 3870
  • [4] BALZARINI J, 2006, IN PRESS LANCET
  • [5] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [6] Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells
    Baribaud, F
    Pöhlmann, S
    Leslie, G
    Mortari, F
    Doms, RW
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (18) : 9135 - 9142
  • [7] SYNERGISTIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN-MEDIATED CELL-FUSION AND INFECTION BY AN ANTIBODY TO CD4 DOMAIN-2 IN COMBINATION WITH ANTI-GP120 ANTIBODIES
    BURKLY, L
    MULREY, N
    BLUMENTHAL, R
    DIMITROV, DS
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (07) : 4267 - 4273
  • [8] CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site
    Clevestig, P
    Pramanik, L
    Leitner, T
    Ehrnst, A
    [J]. JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 607 - 612
  • [9] SEQUENCE AND EXPRESSION OF A MEMBRANE-ASSOCIATED C-TYPE LECTIN THAT EXHIBITS CD4-INDEPENDENT BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN-GP120
    CURTIS, BM
    SCHARNOWSKE, S
    WATSON, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 8356 - 8360
  • [10] Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
    Dorr, P
    Westby, M
    Dobbs, S
    Griffin, P
    Irvine, B
    Macartney, M
    Mori, J
    Rickett, G
    Smith-Burchnell, C
    Napier, C
    Webster, R
    Armour, D
    Price, D
    Stammen, B
    Wood, A
    Perros, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4721 - 4732